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Abstract
Background: Onchocerciasis (river blindness) caused by the parasite Onchocercavolvulus and transmitted by riverine
Simulium spp. (Black flies) is targeted for elimination in Africa. This is a significant change in strategy from the
‘control’ of meso- and hyper-endemic areas through mass drug administration (MDA) with Mectizan® (ivermectin),
to the ‘elimination’ in all endemic areas where a range of interventions may be required. The most significant
challenges of elimination in low transmission or hypo-endemic areas are two-fold. First, there are vast remote areas
where the focality of low transmission is relatively undefined. Second, the treatment with ivermectin increases the
risk of serious adverse events (SAEs) in individuals with high parasitaemias of Loa loa, a filarial parasite widespread
in Central and West Africa, which causes Tropical eye worm and transmitted by Chrysops spp. (Deer flies).
Discussion: We therefore propose novel mapping approaches using remote sensing satellite and modelled
environmental data to be used in combination with rapid field surveys to help resolve the problems of targeting
the expansion of onchocerciasis elimination activities in L. loa co-endemic areas. First, we demonstrate that
micro-stratification overlap mapping (MOM) of available onchocerciasis and loiasis prevalence maps can be used
to identify 12 key high risk areas, where low O. volvulusand high L. loa transmission overlap, which we define as
“hypo-endemic hotspots”. Second we show that integrated micro-mapping of prevalence data, and the use of
environmental data to delineate riverine and forest risk factors associated with Simulium spp. and Chrysops spp.
vector habitats can further help to define target intervention areas i.e. secondary hotspots within hotspots, to
help avoid the risk of SAEs.
Summary: These mapping examples demonstrate the value of bringing prevalence, entomological and
ecological information together to develop maps for planned implementation and targeted strategies. This is
critical as better mapping may the reduce costs and lower the L. loa associated risks, especially if there are
extensive areas of low endemicity that may require treatment with ivermectin or alternative strategies. Novel
cost-effective approaches are necessary if elimination of O.volvulus transmission in Africa is to be achieved in an
efficient and safe way by the goal of 2025.
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Background
Onchocerciasis (river blindness) is a neglected tropical
disease (NTD), caused by the parasite Onchocerca volvu-
lus and transmitted by riverine vector of Simulium
spp.(Blackflies) [1, 2]. The highest burden of onchocercia-
sis occurs in Africa, and over the past two decades the
African Programme for Onchocerciasis Control (APOC)
has focussed its efforts on the control of high transmission
meso- and hyper-endemic areas through mass drug ad-
ministration (MDA) with the drug Mectizan® (ivermectin),
based on the community-directed treatment with iver-
mectin (CDTi) platform [3–5]. The CDTi approach has
largely been effective and sustainable, and in 2010 a mo-
mentous decision was made to expand the programme to
include all endemic areas and aim for the elimination of
onchocerciasis by the year 2025 [6, 7].
The decision to eliminate O.volvulus transmission in
Africa poses significant logistic and resource challenges
to country programmes [7, 8]. However, most import-
antly before any interventions can be scaled up in the
new low transmission or hypo-endemic target areas, it
will be essential to define the distribution and drivers of
transmission as they were not examined in detail follow-
ing the initial rapid epidemiological mapping activities
[9, 10], and the epidemiology may differ significantly to
high transmission areas. Further, the geographical area-
sare vast and remote, and many communities in these
new target areas are drug naïve to ivermectin. The treat-
ment with ivermectin also poses risks of serious adverse
events (SAEs) in individuals with high L. loa parasitae-
mias [11, 12]; therefore,it will be critical to clearly map
the co-distribution with the filarial parasite Loa loa,
which is transmitted by Chrysops spp. (Deer flies) [13].
Thus, onchocerciasis elimination in highly endemic L.
loa areas will require alternative treatment strategies [8],
which may be adapted to the infection in the human
population or the local ecology of the Simulium spp. vec-
tor. To begin to address these challenges, we put forward
the idea that additional innovative mapping methods
using remote sensing satellite technologies and modelled
environmental data are essential to help identify where
the low onchocerciasis transmission overlaps with high
risk L. loa areas, which we describe as ‘hypo-endemic hot-
spots’. We also hypothesize that within these hotspot
zones it is possible to further delineate target areas using
environmental determinants of the specific vector habi-
tats. Here, we present the case for- and provide examples
of- two new mapping approaches which can be used in
combination with the standard rapid epidemiological
methods, to define the high risk hypo-endemic commu-
nities requiring alternative treatment strategies. This will
reduce the time and increase the efficiency in which they
are identified, and help to reduce the extent and related
costs of additional field surveys.
Discussion
Onchocerciasis elimination in context
The decision to progress towards the elimination of
O.volvulus in Africa matches the objectives of the On-
chocerciasis Elimination Programme of the Americas
(OEPA), which successfully used a strategy of twice
yearly treatment of ivermectin in onchocerciasis en-
demic communities, with two countries verified free of
transmission, and three countries under surveillance
with dossiers detailing the data evidence for certification
submitted [6, 14–18]. In Africa, the decision for elimin-
ation was based on studies in previously highly endemic
areas of Senegal and Mali in the basins of the Gambia,
Bakoye and Faleme rivers, where it was demonstrated that
between 15 to 17 years of twice annual or annual iver-
mectin treatment reduced the prevalence to zero in most
communities. There was also a parallel reduction in the
transmission as measured by pool screening of Simulium
spp., where the estimated upper bound of the 95 % confi-
dence of the prevalence of flies carrying infective larvae
was less than 1/1000 parous flies collected [19]. Similar re-
sults in Kaduna State, Nigeria following 15 years of annual
CDTi confirmed that O. volvulus prevalence had declined
to zero in two previously highly endemic foci [19–21].
Initially, the objective of APOC was to sustain the deliv-
ery of ivermectin via CDTi project areas of meso- and
hyper-endemicity defined by two rapid mapping methods,
Rapid Epidemiological Assessment (REA) and Rapid Epi-
demiological Mapping of Onchocerciasis (REMO) [9, 10],
using nodule palpation in 30–50 adult males over the age
of 20 years per village [2]. These rapid epidemiological
mapping methods use geographic attributes to determine
areas likely to be suitable for Simulium spp. breeding. This
approach is rooted in the fact that the vectors of O. volvu-
lus have highly specific riverine breeding site requirements,
and therefore with the aid of topographical maps, it was
possible to make a choice of representative villages most
likely to be seriously affected by onchocerciasis lo-
cated ≤10 km from the riverine breeding sites [9, 10].
APOC also supported vector control in certain settings
where Simulium spp. populations were isolated and there
was limited risk of reinvasion. (e.g. foci in Uganda, Tanzania
and on the island of Bioko, Equatorial Guinea) [4, 22, 23].
The decision to target the elimination of onchocercia-
sis in Africa through MDA has wide logistic, financial,
human resource and policy implications. APOC projects
were initially confined to meso- and hyper-endemic
areas, but now extend to include hypo-endemic areas,
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referred to as ‘low transmission zones’, where the nodule
prevalence was found to be less the 20 % in REMO sur-
veys, which correlate with <35 % microfilaria (Mf) in the
skin [3, 24]. Communities in these low transmission zones
were not previously treated, as they were considered of
less public health importance. Therefore, extensive areas
of lower endemicity outside existing treatment zones may
now require treatment with ivermectin. However the
treatment numbers, locations and related critical cut-offs
of who and where to treat and not-to-treat are not well
defined. In 2011,an estimated 77.3 million people living in
2.8 million km2 had 5–19.9 % nodule prevalence, and an-
other 97.6 million in 3 million km2had <5 % nodule preva-
lence [3]. These estimates were based on 2011 population
estimates, and it is possible prevalence figures pertain to
an era before the start of control (before 2011). It is also
possible that they have changed over the past 5 years, and
either increased with population growth or movement, or
decreased with the potential impact of other large scale
MDA programmes such as lymphatic filariasis (LF), which
also distributes ivermectin [25]. Understanding the popu-
lation dynamics and overlaps with other NTD program-
matic activities will be particularly important in large
highly populated countries such as Nigeria and the Demo-
cratic Republic of Congo (DRC) [26, 27].
Rapid delineation of these low transmission zones to
determine their geographical limits, and the numbers re-
quiring treatment is now critical for the expansion of the
programme and if the goal of elimination is to be
achieved. This is particularly pertinent as the number of
people and geographical area to cover with interventions
(standard or alternative), is more than double the size of
meso- and hyper-endemic areas, and the epidemiology less
defined. Further, it will be important to consider the com-
plexities of L. loa co-endemicity where alternative strat-
egies will be required [8, 28]. Previous mapping methods
of REA and REMO used to define CDTi project areas may
not be practical to use for the low transmission zones,
given the long time in the field they take to conduct, and
the need to access such large populations, in extensive and
remote geographical areas. Therefore, alternative inno-
vative approaches are necessary to increase the speed and
efficiency in which to identify hypo-endemic target areas,
which need to be mapped and treated.
The problem with Loa loa
The wide distribution of L. loa filariasis through Central
and West Africa has and continues to pose a major obs-
tacle for onchocerciasis elimination because the standard
strategy of community wide treatment with ivermectin,
cannot be used due to the risk of SAEs and possible
deathof individuals with high L. loa Mf loads. The risk
of SAEs is high when the Mf loads exceed 8000 Mf/ml,
and the reaction is more severe if the load exceeds
30,000 Mf/ml [29–31]. APOC began to address this
problem over a decade ago by implementing a rapid map-
ping method, Rapid Assessment Procedure for Loiasis
(RAPLOA), which is based on eye worm history and
assesses the proportion of infected people in a community
[13]. The large-scale RAPLOA field surveys helped
produce endemicity risk maps for programmatic use.
RAPLOA prevalence >40 % broadly correlates with >20 %
Mf prevalence, and defines the high risk areas. However
RAPLOA is limited in that the proportion of the popula-
tion with Mf loads over 8,000 Mf/ml and 30,000 Mf/ml is
not well defined across large areas, and these can vary
considerably across different human and geographical
landscapes [32–34]. This uncertainty in risk within popu-
lations has implications for the choice of alternative strat-
egies, which may include different drug regimens and/or
targeted vector control.
New mapping approaches
We have previously developed two mapping strategies to
address the problems associated with L. loa co-endemicity.
The first, the micro-stratification overlap mapping (MOM)
strategy, has been used to determine the levels at which
the implementation of LF programmes is most efficiently
deployed in L. loaco- endemic areas, using examples from
the DRC, Nigeria and South Sudan [26, 27, 35]. The MOM
strategy has also been used to broadly define environmen-
tal characteristics of L. loa in Central Africa around the
Congo River Basin [36], and to highlight the zoogeography
of filarial infections [37], building on the initial use of
remotely sensed imagery associated with L. loa prevalence
data [38]. The second, the integrated micro-mapping strat-
egy, has been used to inform mapping and alternative
treatment strategies for LF elimination in L. loa co-
endemic areas [39], and also to overlap different O. volvu-
lus and L. loa transmission zones at a micro-epidemiologic
scale in order to highlight the prevalence distribution of
SAEs in DRC [12].
Here, we expand on these strategies, and hypothesise
that by using these additional mapping methods, we can
first broadly identify where the main ‘hypo-endemic hot-
spots’are located. Second, we can delineate the high risk
and treatment target areas within each hotspot using the
environmental determinants of the riverine breeding
sites of Simulium spp. [40, 41], and the forest canopy
habits of Chrysops spp. where biting rates are likely to
be highest and hence transmission will be concentrated
[42–44]. Both methods use geographical information sys-
tems (GIS) software to examine high resolution remote
sensing satellite imagery and modelled environmental
data. Compared with field surveys that could take months
to years to complete with high costs associated with
personnel and transport, these mapping methods require
the specialised knowledge and skills of a few GIS, remote
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sensing and environmental experts, which could complete
the related work within weeks to months.
Hypo-endemic hotspot case studies
The specific steps we have undertaken to develop these
new strategies for ‘hypo-endemic hotspots’ in Central and
West Africa are outlined below in bullet form in relation
to Figs. 1 and 2, which were developed using GIS soft-
ware ArcGIS 10 (ESRI, Redlands, CA).
A. Micro-stratification overlap mapping (MOM) to identify
‘hypo-endemic hotspots’
 The first step was to define low transmission/hypo-
endemic areas of onchocerciasis. While ground-
truth data are not widely available due to the lack of
mapping in low risk zones, data from modelled
prevalence distributions based on REMO mapping
were extracted and remapped to highlight the extent
of 5 % to 20 % onchocerciasis [3]. These hypo-
endemic areas are illustrated in green in Fig. 1a, and
show the potentially large geographical expanse of
low transmission/hypo-endemic zones that need to
be targeted for elimination.
 The second step was to define areas of high
transmission/hyper-endemic L. loa. These areas
were derived from data from modelled prevalence
distributions from the large-scale RAPLOA map
[13], which were extracted and remapped to
highlight the extent of >40 % estimated loiasis
prevalence. The hyper-endemic areas are
illustrated in dark red in Fig. 1b, and show the
large focal and unusual distribution around the
Congo River basin [36].
 The third step was to overlap these stratified layers of
prevalence to highlight where the hypo-endemic
onchocerciasis areas geographically coincided with
hyper-endemic L. loa areas. Figure 1c demonstrates
there was irregular co-distribution, highlighted in
orange, with the majority of overlapping areas in the
western region of Central Africa in the five countries
of Cameroon, Central Africa Republic, Congo,
Equatorial Guinea (mainland) and Gabon. Smaller
overlapping areas were also found in the five countries
of Angola, Chad, DRC, Nigeria, and South Sudan.
 The final step was to identify selected areas which
could be geographically defined as 100 to 150 km2
areas with overlapping hypo-endemic onchocerciasis
and hyper-endemic L. loa and therefore defined as
‘hypo-endemic hotspots’ for further micro-mapping and
environmental delineation. The 12 primary hotspots
identified in Fig. 1c were found to have potentially
different exposures to ivermectin as seven were in
areas that coincided with CDTi areas, and may have
received or be in close proximity to communities
receiving ivermectin according to an APOC treatment
map [45]. Completely drug naïve areas were hotspots#
7, 8, 9, 10 and 11 and may be considered high risk
Fig. 1 Maps of onchocerciasis and L. loa and overlapping hypo-and hyper-endemic zones and primary hotspots
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areas of SAEs if ivermectin were to be administered,
and as such should be considered as pilot areas for the
scale up of alternative treatment strategies.
B. Integrated micro-mapping to delineate environment
predictors and intervention targets
 The first step was to identify the availability of
prevalence distributions within a hotspot zone.
Hotspot # 11 in the Bas Congo region of DRC was
used an example as onchocerciasis and loiasis
prevalence data were available from an integrated
micro-mapping activity, with hyper and hypo areas
of both diseases across 144 sites and a reported
history of SAEs in hyper-endemic areas [12, 46].
 The second step was to determine the different
prevalence patterns of onchocerciasis in relation to
the river systems available from remotely sensed
HydroSHEDS flow accumulation data [47]. Figure 2a
shows the hyper-endemic onchocerciasis areas of
20-40 % and > 40 % prevalence showing their close
proximity to the Congo River itself, with the majority
of sites with >40 % within 15kms of this high
accumulation flow river. Figure 2b shows the wider
distribution of hypo-endemic onchocerciasis, with
sites further from the Congo River itself and which
were found to geographically overlap to a greater
degree with forested areas as represented by remotely
sensed vegetation canopy height [48].
 The third step was to determine the high risk L. loa
areas (>40 % prevalence) within the hotspot as this
poses the greatest risk of SAEs and identifies where
alternative strategies would need to be targeted at a
micro-level. Figure 2c highlights the distribution of
hyper-endemic L. loa in tropical forested areas with
an average of 10 m canopy height. Figure 2d shows
the specific sites with overlapping hypo-endemic
onchocerciasis and hyper-endemic L. loa (n = 24 sites),
which were found to occur within an approximate
50 km2 area, and considered as a ‘secondary hotspot’
(i.e. hotspot within the hotspot)
 The final step was to identify target areas within the
‘secondary hotspot’ determined by potential key
environmental proxies for low transmission such as
secondary rivers and tributaries with lower flow
accumulations. Figure 2e shows the 10 km buffer
zone (in grey) around the rivers with lower flow
accumulations and highlights that the majority of
hypo/hyper sites (71 %; 17/24 sites) were within this
defined riverine buffer area.
Fig. 2 An example of micro-mapping and environmental delineation in Bas Congo, Democratic Republic of Congo
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Summary
Here we demonstrate that the combination of micro- over-
lapping and integrated eco-epidemiological mapping can
be used to identify and delineate ‘hypo-endemic hotspots’of
onchocerciasis where they may be at significant risk of
SAEs due to the high prevalence of L. loa, if ivermectin is
used for elimination. These areas were hitherto not
regarded as being in need of treatment as it was considered
that onchocerciasis was not a significant public health
problem. With the emphasis on elimination of the disease
from Africa by 2025, it is clear that at least a proportion of
low transmission zones require some form of treatment.
The previously used mapping approaches of REA, REMO
and RAPLOA to identify high risk onchocerciasis and L.
loa areas are not practical to use across the entire low
transmission zones, due to the high financial costs, and
the time (months to years) required to conduct surveys in
remote and inaccessible areas of Central and West Africa.
We advocate that our two strategies when used together
in combination with the standard rapid REA, REMO and
RAPLOA methods will not only reduce the time (weeks
to months) required to identify these high risk areas, but
also prioritize these hotspots as zones where increased
vigilance will be required and where resources will need to
be put in place by implementing partners to ensure any
SAEs are provided for adequately. While there are some
limitations with finding suitably qualified experts, and the
use of modelled data and remote sensing imagery e.g. dif-
ferent scales, resolution and some high costs of images
(much less than the costs of field surveys), we consider
that this approach is an important first step to under-
stand the scope of the problem, and is a novel and
practical way to at least initiate activities and pilot im-
plementation in selected ‘hypo-endemic hotspots’.
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